Tune Therapeutics develops precision epigenome editing therapies that can tune gene expression up or down without altering DNA sequence. Their TEMPO platform uses engineered transcription factors fused to epigenetic effectors to durably modulate disease-associated genes, targeting oncology, immunology, and genetic disease.